GT Biopharma Inc. (GTBP) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    GT Biopharma Inc.

    NASDAQ: GTBP · Real-Time Price · USD
    0.97
    -0.17 (-14.91%)
    At close: Aug 28, 2025, 3:59 PM
    0.96
    -0.61%
    After-hours: Aug 28, 2025, 07:58 PM EDT

    GT Biopharma Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -13.16M -7.6M -20.88M -58.01M
    Depreciation & Amortization
    		 n/a n/a n/a n/a
    Stock-Based Compensation
    		 230K 2.2M 7.65M 33.93M
    Other Working Capital
    		 -109K -137K 41K 863K
    Other Non-Cash Items
    		 -800K -5.28M 10K 538K
    Deferred Income Tax
    		 n/a n/a n/a n/a
    Change in Working Capital
    		 828K 1.82M -1.99M 7.94M
    Operating Cash Flow
    		 -12.9M -8.85M -15.22M -15.61M
    Capital Expenditures
    		 n/a n/a n/a n/a
    Cash Acquisitions
    		 n/a n/a n/a n/a
    Purchase of Investments
    		 12.89M n/a 12.14M -23.04M
    Sales Maturities Of Investments
    		 n/a n/a 12.14M n/a
    Other Investing Acitivies
    		 n/a -2.01M -12.14M n/a
    Investing Cash Flow
    		 12.89M -2.01M 12.14M -23.04M
    Debt Repayment
    		 n/a n/a n/a 1.21M
    Common Stock Repurchased
    		 n/a n/a -224K n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 n/a n/a n/a 16.43M
    Financial Cash Flow
    		 2.98M 6.27M -224K 42.32M
    Net Cash Flow
    		 2.96M -4.59M -3.3M 3.67M
    Free Cash Flow
    		 -12.9M -8.85M -15.22M -15.61M

    Add to Watchlist